Share
Market Research Report

GLOBAL ANTISENSE & RNAI THERAPEUTICS MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2026-2033)

Segmentation
  • By TechnologyRNA Interference and Antisense RNA
  • By ApplicationGenetic Disease · Cancer · Infectious Disease · Neurodegenerative Disorders · Cardio Metabolic & Renal Disorders · Ocular Disorders · Respiratory Disorders · Skin Disorders and Others
  • By Route of AdministrationIntravenous Injections · Intrathecal Injections · Subcutaneous Injections and Others
  • By GeographyNorth America · Europe · Asia Pacific · Latin America · Middle East and Africa
  • Published In27 Apr 2026
  • Report CodeCMI6545
  • Pages250+
  • FormatsExcel and PDF
  • Base Year2025
  • Estimated Year2026
  • Historical Range2020 - 2024
  • Forecast Period2026-2033
  1. Research Objectives and Assumptions

    • Research Objectives
    • Assumptions
    • Abbreviations
  2. Market Purview

    • Report Description
      • Market Definition and Scope
    • Executive Summary
      • Market Snippet, By Technology
      • Market Snippet, By Application
      • Market Snippet, By Route of Administration
      • Market Snippet, By Region
    • Coherent Opportunity Map (COM)
  3. Market Dynamics, Regulations, and Trends Analysis

    • Market Dynamics
      • Drivers
        • Promising Innovations in Drug Delivery Systems
      • Restraints
        • High Manufacturing Cost of RNA Therapeutics
      • Opportunities
        • Untapped Emerging Markets
    • Impact Analysis
    • Key Highlights
    • Regulatory Scenario
    • Product launch/Approvals
    • PEST Analysis
    • PORTER’s Analysis
    • Merger and Acquisition Scenario
  4. Antisense & RNAi Therapeutics Market , By

    Technology, 2021 - 2033, (US$ Bn)

    • Introduction
      • Market Share Analysis, 2026 and 2033 (%)
      • Y-o-Y Growth Analysis, 2022 – 2033
      • Segment Trends
    • RNA Interference
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
    • Antisense RNA
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
  5. Antisense & RNAi Therapeutics Market , By

    Application, 2021 - 2033, (US$ Bn)

    • Introduction
      • Market Share Analysis, 2026 and 2033 (%)
      • Y-o-Y Growth Analysis, 2022– 2033
      • Segment Trends
    • Genetic Disease
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Billion)
    • Cancer
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Billion)
    • Infectious Disease
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Billion)
    • Neurodegenerative Disorders
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Billion)
    • Cardio Metabolic & Renal Disorders
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Billion)
    • Ocular Disorders
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Billion)
    • Respiratory Disorders
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Billion)
    • Skin Disorders
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Billion)
    • Others
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Billion)
  6. Antisense & RNAi Therapeutics Market , By

    Route of Administration, 2021 - 2033, (US$ Bn)

    • Introduction
      • Market Share Analysis, 2026 and 2033 (%)
      • Y-o-Y Growth Analysis, 2022– 2033
      • Segment Trends
    • Intravenous Injections
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Billion)
    • Intrathecal Injections
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Billion)
    • Subcutaneous Injections
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Billion)
    • Others
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Billion)
  7. Antisense & RNAi Therapeutics Market , By

    Region, 2021 - 2033, (US$ Bn)

    • Introduction
      • Market Share Analysis, By Country, 2026 and 2033 (%)
      • Y-o-Y Growth Analysis, For Country 2022–2033
      • Country Trends
    • North America
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2021 - 2033,(US$ Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033,(US$ Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2021 - 2033,(US$ Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033,(US$ Bn)
        • U.S.
        • Canada
    • Europe
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2021 - 2033,(US$ Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033,(US$ Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2021 - 2033,(US$ Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033,(US$ Bn)
        • Germany
        • U.K.
        • Spain
        • France
        • Italy
        • Russia
        • Rest of Europe
    • Asia Pacific
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2021 - 2033,(US$ Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033,(US$ Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2021 - 2033,(US$ Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033,(US$ Bn)
        • China
        • India
        • Japan
        • Australia
        • South Korea
        • ASEAN
        • Rest of Asia Pacific
    • Latin America
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2021 - 2033,(US$ Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033,(US$ Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2021 - 2033,(US$ Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033,(US$ Bn)
        • Brazil
        • Argentina
        • Mexico
        • Rest of Latin America
    • Middle East
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2021 - 2033,(US$ Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033,(US$ Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2021 - 2033,(US$ Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033,(US$ Bn)
        • GCC Countries
        • Israel
        • Rest of Middle East
    • Africa
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2021 - 2033,(US$ Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033,(US$ Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2021 - 2033,(US$ Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Country/Region , 2021 - 2033,(US$ Bn)
        • South Africa
        • North Africa
        • Central Africa
  8. Competitive Landscape

    • Benitec Biopharma Inc.
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Silence Therapeutics
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Strategies
    • Ionis Pharmaceuticals, Inc
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Strategies
    • Bio-Path Holdings Inc.
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Strategies
    • Percheron Therapeutics Limited
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Strategies
    • GSK plc
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Strategies
    • Olix Pharmaceuticals, Inc.
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Strategies
    • Sanofi
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Strategies
    • Alnylam Pharmaceuticals, Inc.
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Strategies
    • Arbutus Biopharma
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Strategies
    • Analyst Views
  9. Section

    • Research Methodology
    • About us

*Browse 38 market data tables and 34 figures on “

Antisense & RNAi Therapeutics

Market” - Global forecast to 2033